ADVERTISEMENT

Iceland

Nordic Medtech Experts Urge More Collaboration On Health Technology Assessments

European cross-country HTA collaborations have much to learn from each other to keep prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

Cross-Country HTA Collaboration To Focus On Health Economics & RWE

European cross-country HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

Nordic HTA Body Tells Pharma Users: ‘Feel the Fear And Do It Anyway’

It is time for companies to take part in cross-country health technology assessments and stop only asking “what’s in it for me?”

Nordic HTA Collaboration: Feel The Fear And Do It Anyway

It is time for companies to take part in cross-country health technology assessments and stop asking “what’s in it for me?”

Global Pharma Guidance Tracker – September 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Another Funding Win For Chiesi In Europe As Scotland OKs Elfabrio

Scotland’s health technology assessment body has agreed to reimburse Chiesi’s Elfabrio for Fabry disease, mirroring the decision from several other European countries – however, France turned down the rare disease drug, while Germany questioned its benefit.

Nordic HTA Initiative Offers ‘Practice Ground’ For Worrisome EU-Level Joint Clinical Assessment

Industry shoulders some blame for growing unease about joint clinical assessments after its failure to participate in pilots.

Alvotech Willing And Able To Go Stride For Stride On Pembrolizumab Manufacturing

Alvotech stepped into its 2023 annual financing results call bursting with positive news and momentum, on the back of obtaining USFDA approval for its biosimilar Humira product and a bullish outlook for its strong pipeline of biosimilar candidates.

Global Pharma Guidance Tracker – January 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Pharma Guidance Tracker – December 2023

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.